ArticleOphthalmology and therapy2025

One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.

Anne Tillmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.